Eastgate Biotech Corp Debt Instrument, Increase, Accrued Interest
Eastgate Biotech Corp reported Debt Instrument, Increase, Accrued Interest of $175.45 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2019-03-04.
Discontinued › Notes
us-gaap:DebtInstrumentIncreaseAccruedInterest · last filed 2019-03-04
- Eastgate Biotech Corp debt instrument, increase, accrued interest for the quarter ending 2017-09-30 was $124.29K, a 76.07% increase year-over-year.
- Eastgate Biotech Corp debt instrument, increase, accrued interest for the quarter ending 2017-06-30 was -$6.73K.
- Eastgate Biotech Corp debt instrument, increase, accrued interest for the quarter ending 2017-03-31 was $57.89K, a 81.38% increase year-over-year.
- Eastgate Biotech Corp debt instrument, increase, accrued interest for the quarter ending 2016-09-30 was $70.59K.
| Period end | Debt Instrument, Increase, Accrued Interest 3 month | Debt Instrument, Increase, Accrued Interest 3 month as first filed | Debt Instrument, Increase, Accrued Interest 6 month | Debt Instrument, Increase, Accrued Interest 9 month | Debt Instrument, Increase, Accrued Interest 154 month |
|---|---|---|---|---|---|
| 2017-09-30 | $124.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-04 | $117.56K derived: sum of 2 quarters · filed 2019-03-04 | $175.45K 10-Q · filed 2019-03-04 | ||
| 2017-06-30 | -$6.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-18 | $51.16K 10-Q · filed 2018-12-18 | |||
| 2017-03-31 | $57.89K 10-Q · filed 2018-08-17 | ||||
| 2016-09-30 | $70.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-04 | $70.59K derived: sum of 2 quarters · filed 2019-03-04 | $102.51K 10-Q · filed 2019-03-04 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-18 | $31.92K 10-Q · filed 2018-12-18 | |||
| 2016-03-31 | $31.92K 10-Q · filed 2018-08-17 | ||||
| 2012-06-30 | $25.79K 10-Q · filed 2012-10-26 | $20.16K 10-Q · filed 2012-08-20 | $17.19K 10-Q · filed 2012-10-26 |